Eloxx Pharmaceuticals (ELOX) Financials

$15.75

$-0.53 (-3.26%)

As on 11-Sep-2026 16:00EDT

Market cap

$54 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

4.6

P/B Ratio

1.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	6.36	--	--	--	--
Cost of Revenue	--	--	--	0.70	0.96	0.57
Gross Profit	--	6.36	--	-0.70	-0.96	-0.57
Operating Expenses	6.44	8.83	17.29	33.72	41.39	28.87
Operating Profit (EBIT)	-6.44	-2.47	-17.29	-34.42	-42.35	-29.44
Other Income	--	--	--	--	--	-1.12
Profit before Tax	-6.00	-3.14	-17.05	-36.14	-66.73	-34.58
Provision for Tax	--	--	--	-0.08	1.26	1.41
Profit after Tax (Net Income)	-6.00	-3.14	-17.05	-36.07	-66.73	-34.58
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-66.73	-34.58

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-11.91	-24.34	-22.60	-10.66	22.38	9.78
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	1.61	8.69	12.80	5.24
Current Liabilities	17.18	27.31	22.70	23.09	9.96	9.84
Total Liabilities	5.27	2.98	1.71	21.12	45.14	26.03

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	--	0.16	0.99	1.66	0.13
Current Assets	5.27	2.98	1.55	20.13	43.48	25.89
Total Assets	5.27	2.98	1.71	21.12	45.14	26.03
Total Debt*	1.00	6.52	3.97	13.38	13.46	12.00
Net Current Assets	-11.91	-24.34	-21.15	-2.96	33.53	16.06

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-6.33	-4.72	-14.34	-31.85	--	--
Cash Flow from Investing Activities	0.00	0.04	0.31	-0.07	--	--
Cash from Financing Activities	11.00	3.44	-4.08	8.81	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	--	-12.58	-68.27	-183.16	-30.90	-34.45
Cash EPS ($)	--	-11.93	-65.03	-179.63	-30.45	-33.88
Adjusted Book Value ($)	--	--	--	--	10.36	9.74
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-18.88	-57.41	-161.73	-16.21	-28.06
Free Cash Flow per Share ($)	--	-18.88	-57.41	-162.07	-16.25	-28.06

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	41.75	17.25	214.39	-187.03	-231.59	-94.30
ROE (%)	33.08	13.39	102.55	-615.23	-414.93	-150.36
ROA (%)	-145.40	-134.09	-149.37	-108.86	-187.53	-81.38
EBIT Margin (%)	--	-31.44	--	--	--	--
Net Margin (%)	--	-49.43	--	--	--	3,081.73
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-1.00	--	--	--	--	--
EBIT Growth (%)	--	87.43	53.49	47.77	-122.40	41.77
Net Profit Growth (%)	-90.74	81.57	52.71	45.95	-92.98	32.03
EPS Growth (%)	--	0.82	0.63	-4.93	0.10	0.32
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	--	-0.02	-0.01	-0.02	-0.12
Price / Book Value	--	--	-0.01	-0.03	0.07	0.41
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	-0.21	0.17	0.42	0.30
Close Price ($)	--	--	1.20	1.82	28.25	159.20
High Price ($)	--	--	10.90	32.00	199.20	326.46
Low Price ($)	--	--	--	1.70	22.88	57.60
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-0.08	-0.27	-0.18	-1.26	0.60	1.23
Short term debt to equity ratio	-0.08	-0.27	-0.10	-0.44	0.03	0.58
Current Ratio	0.31	0.11	0.07	0.87	4.37	2.63
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	-1.75	-13.82	-17.54	-52.00	-20.89

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	42.74	--	--	--	--
Asset Turnover	--	2.71	--	--	--	--
Receivable days	--	78.06	--	--	--	--
Inventory Days	--	--	--	--	--	452.88
Payable days	--	--	--	1,155.92	353.84	752.25
Cash Conversion Cycle	--	--	--	--	--	--